Seminario web

The new rules of procurement: From cost center to strategic growth engine

Procurement is under more pressure than ever, and it has a greater opportunity to create strategic value. Today’s procurement leaders are being asked to reduce costs, strengthen supply continuity, manage risk, improve supplier performance, and support business growth at the same time. As supply networks grow more complex and expectations continue to rise, procurement is taking on a broader role across the business. Join senior leaders from UCB Biopharma, Jazz Pharmaceuticals, and Cencora for a live webinar on Thursday, November 12th at 11am ET. Discover how forward-looking procurement organizations are responding to these pressures and redefining what leadership looks like in practice.

Key highlights

  • How leading organizations are measuring procurement success beyond cost savings
  • Practical ways to balance cost control with resilience and supply continuity
  • How to evaluate total business impact, not purchase price alone
  • Approaches to strengthening supplier partnerships and supplier ecosystem performance
  • The capabilities that are expected to shape future-ready procurement teams, including data, collaboration, risk management, and automation

Moderator:
Hugo Pessoa, Senior Director, Global Consulting Services, Global Strategic Accounts, Cencora

Speakers:
Gerardo Fuertes, Senior Director, Business Development, 3PL, Alloga Europe, Cencora
Mark Cawley, Associate Director, Research Procurement (Regulatory Affairs, PV and Medical Affairs), Jazz Pharmaceuticals
Baudoin Kopp, Global Category Lead, Supply Chain, CTS & Utilities, UCB Biopharma

Estamos aquí para ayudar

Póngase en contacto con nuestro equipo hoy mismo para obtener más información sobre cómo Cencora está ayudando a dar forma al futuro de la atención sanitaria.

Recursos relacionados

Boletín

HTA trimestral otoño de 2026

Artículo

Colisión entre la JCA de la UE y la NMF de los EE. UU.: La próxima frontera global de riesgo de fijación de precios y acceso al mercado

Artículo

El futuro de la atención administrada: Cómo la IA puede transformar las operaciones farmacéuticas para 2030